Long-Term Risk for Device-Related Complications and Reoperations After Implantable Cardioverter-Defibrillator Implantation: An Observational Cohort Study
- PMID: 27135392
- DOI: 10.7326/M15-2732
Long-Term Risk for Device-Related Complications and Reoperations After Implantable Cardioverter-Defibrillator Implantation: An Observational Cohort Study
Abstract
Background: Long-term nonfatal outcomes after implantable cardioverter-defibrillator (ICD) placement are poorly defined.
Objective: To determine the long-term risk for ICD-related complications requiring reoperation or hospitalization and reoperation for reasons other than complications, and to assess associated patient and device characteristics.
Design: Observational cohort study of ICD implantations from the National Cardiovascular Data Registry ICD registry linked with Medicare fee-for-service claims data.
Setting: 1437 U.S. hospitals.
Patients: 114 484 patients aged 65 years or older (mean, 74.8 years [SD, 6.2]; 72.4% male) receiving an ICD for the first time from 2006 to 2010 (single-chamber, 19.8%; dual-chamber, 41.3%; cardiac resynchronization therapy with a defibrillator [CRT-D], 38.9%).
Measurements: Rate and cumulative incidence of ICD-related complications requiring reoperation or hospitalization and reoperation for reasons other than complications.
Results: During a median follow-up of 2.7 years (interquartile range, 1.8 to 3.9 years), 40 072 patients died, representing 12.6 (95% CI, 12.5 to 12.7) deaths per 100 patient-years of follow-up. When the risk for death was accounted for, there were 6.1 (CI, 6.0 to 6.2) ICD-related complications per 100 patient-years that required reoperation or hospitalization and 3.9 (CI, 3.8 to 4.0) reoperations per 100 patient-years for reasons other than complications. Overall, 10 patients had complications or reoperation per 100 patient-years of follow-up. Younger age at implantation (65 to 69 vs. >85 years) (hazard ratio [HR], 1.55 [CI, 1.43 to 1.69]), receipt of a CRT-D device (HR, 1.38 [CI, 1.31 to 1.45]) versus a single-chamber device, female sex (HR, 1.16 [CI, 1.12 to 1.21]), and black race (HR, 1.14 [CI, 1.05 to 1.23]) were associated with the greatest increased risks for ICD-related complications.
Limitation: The analysis was limited to Medicare fee-for-service patients aged 65 years or older.
Conclusion: Patients have a high rate of device-related complications and reoperation for other causes after ICD implantation. Risks of ICD implantation and strategies to reduce them should be actively considered before implantation.
Primary funding source: American College of Cardiology Foundation's National Cardiovascular Data Registry.
Similar articles
-
Association of Physician Specialty With Long-Term Implantable Cardioverter-Defibrillator Complication and Reoperations Rates.Circ Cardiovasc Qual Outcomes. 2019 Jun;12(6):e005374. doi: 10.1161/CIRCOUTCOMES.118.005374. Epub 2019 Jun 12. Circ Cardiovasc Qual Outcomes. 2019. PMID: 31185734 Free PMC article.
-
Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.JAMA Netw Open. 2021 Jan 4;4(1):e2035470. doi: 10.1001/jamanetworkopen.2020.35470. JAMA Netw Open. 2021. PMID: 33496796 Free PMC article.
-
Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.Ann Intern Med. 2014 May 6;160(9):603-11. doi: 10.7326/M13-1879. Ann Intern Med. 2014. PMID: 24798523
-
Longitudinal Outcomes of Subcutaneous or Transvenous Implantable Cardioverter-Defibrillators in Older Patients.J Am Coll Cardiol. 2022 Mar 22;79(11):1050-1059. doi: 10.1016/j.jacc.2021.12.033. J Am Coll Cardiol. 2022. PMID: 35300816
-
Assessment on Implantable Defibrillators and the Evidence for Primary Prevention of Sudden Cardiac Death [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jun 26. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jun 26. PMID: 25356453 Free Books & Documents. Review.
Cited by
-
Assessment of Psychological Implications and Quality of Life After Different Cardiac Device Implantation in Saudi Arabia.Cureus. 2024 Jan 15;16(1):e52338. doi: 10.7759/cureus.52338. eCollection 2024 Jan. Cureus. 2024. PMID: 38361709 Free PMC article.
-
Predicting long-term survival after de novo cardioverter-defibrillator implantation for primary prevention: A population based study.Heliyon. 2023 Dec 6;10(1):e23355. doi: 10.1016/j.heliyon.2023.e23355. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38223713 Free PMC article.
-
Simultaneous subcutaneous implantable cardioverter-defibrillator and leadless pacemaker implantation for patients at high risk of infection: a retrospective case series report.J Interv Card Electrophysiol. 2023 Nov 8. doi: 10.1007/s10840-023-01684-9. Online ahead of print. J Interv Card Electrophysiol. 2023. PMID: 37938506 Review.
-
Remote Monitoring of Cardiac Implantable Electronic Devices: What is the Evidence?Curr Heart Fail Rep. 2023 Feb;20(1):12-23. doi: 10.1007/s11897-023-00586-1. Epub 2023 Jan 26. Curr Heart Fail Rep. 2023. PMID: 36701019 Free PMC article. Review.
-
The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication.Heart Rhythm O2. 2022 Oct 21;3(5):589-596. doi: 10.1016/j.hroo.2022.09.006. eCollection 2022 Oct. Heart Rhythm O2. 2022. PMID: 36340497 Free PMC article. No abstract available.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials